Age-related macular degeneration is a major cause of vision impairment in the Western world among people of 55 years and older. Recently we have shown that autophagy is dysfunctional in the retinal pigment epithelium (Rpe) of the AMD donor eyes (AMD Rpe). We also showed increased reactive oxygen (RoS) production, increased cytoplasmic glycogen accumulation, mitochondrial dysfunction and disintegration, and enlarged and annular LAMP-1-positive organelles in AMD RPE. However, the underlying mechanisms inducing these abnormalities remain to be elucidated. Here, by performing a comprehensive study, we show increased PAPR2 expression, deceased nAD+, and SIRT1, increased PGC-1α acetylation (inactive form), lower AMpK activity, and overactive mtoR pathway in AMD Rpe as compared to normal Rpe. Metabolomics and lipidomics revealed dysregulated metabolites in AMD Rpe as compared to normal Rpe, including glycerophospholipid metabolism, involved in autophagy, lipid, and protein metabolisms, glutathione, guanosine, and L-glutamic acid, which are implicated in protection against oxidative stress and neurotoxicity, further supporting our observations. our data show dysregulated metabolic pathways as important contributors to AMD pathophysiology, and facilitate the development of new treatment strategies for this debilitating disease of the visual system.
Results
increased PARP2 expression, decreased nAD+, dysfunctional AMPK/SIRT1/PGC-1α pathway in AMD Rpe. Isolated native RPE from normal and AMD deceased donor eyes were cultured for 4 weeks to obtain monolayer of confluent RPE cells, as explained in our previous work, prior to performing any experiments 10 (Fig. 1A) ( Supplementary Table 1 ). We performed RNA sequencing (RNAseq) on native AMD RPE and normal native RPE cultured from AMD and normal eye donors. RNAseq revealed that PARP2 expression levels were increased in AMD RPE as compared to normal RPE (Supplementary Table 2 ). To further confirm our RNAseq data, we performed qRT-PCR on AMD RPE and normal RPE. Our qRT-PCR data supported the RNAseq results and showed a significant increase in PARP2 expression in AMD RPE compared to normal RPE (Fig. 1B) . We also measured NAD+ levels in normal and AMD RPE. Our data showed a significant decrease in total NAD (NADt) levels in AMD RPE compared to normal RPE (Fig. 1C ). We then evaluated the SIRT1 levels using western blot in normal and AMD RPE. Western blot, followed by densitometry analysis, revealed a significant decrease in SIRT1 protein levels in the AMD RPE as compared to normal RPE (Fig. 1D,E ). Since SIRT1 deacetylates and activates PGC-1α, to test SIRT1 reduced activity, we measured the PGC-1α acetylated protein levels in native AMD RPE, as compared to normal RPE by immunoprecipitation (IP). IP followed by densitometry analysis revealed increased PGC-1α acetylated (inactive) form in native AMD RPE as compared to normal native RPE (Fig. 1F,G) , further supporting our observations.
To test the AMPK activity, we analyzed time-dependent phosphorylation of AMPK by IGF-1 and observed significantly higher AMPK phosphorylation at 30 min time point in normal RPE as compared to AMD RPE by western blot followed by densitometry analysis ( Fig. 2A,B ). To further test the AMPK activity, we also measured the Acetyl-CoA carboxylase (ACC), a crucial enzyme in the biosynthesis and oxidation of fatty acids that is a direct AMPK target 42 . Western blot using anti pACC antibody followed by densitometry analysis revealed a significant decrease in pACC in AMD RPE as compared to normal RPE (Fig. 2C,D) .
Dysregulated AMPK/SIRT1 and PGC-1α pathway, which could directly affect mitochondrial metabolism and biogenesis, led us to evaluate the RNAseq data for the mitochondrial genes such as MRPL16 and PMAIP1 in the AMD RPE as compared to normal RPE. MRPL16 (Mitochondrial Ribosomal Protein L16) is a protein-coding gene and plays a role in mitochondrial translation 43 . The PMAIP1 (Phorbol-12-Myristate-13-Acetate-Induced Protein 1), also known as Noxa, stimulates apoptosis by activation of caspases 44 . The RNAseq showed increased expression of MRPL16 and PMAIP1 in the AMD RPE as compared to normal RPE (Supplementary Table 2 ). The RNAseq also showed differentially expressed genes that regulate mitochondrial function, such as MDH1 (Malate Dehydrogenase 1). MDH1 is an enzyme that catalyzes the reversible conversion of oxaloacetate and malate using NAD+/NADH 45, 46 . Real-Time PCR further confirmed the RNAseq data for MRPL16, PMAIP1, and MDH1 and showed a significant increase in the expression of these three genes in the AMD RPE as compared to normal RPE ( Supplementary Fig. 1A ,D,G). We also focused on the MAPK3 (Mitogen-Activated Protein Kinase 3), a member of the MAP kinase family that is shown to play important roles in multiple cellular functions, including cell cycle progression, proliferation, differentiation and apoptosis in response to extracellular stimuli 47 . MAPK3 was not significantly changed in the AMD vs. normal RPE based on the RNAseq data ( Supplementary Table 2 ). However, Real-Time PCR confirmed decreased expression of MAPK3 in the AMD RPE as compared to normal RPE ( Supplementary Fig. 1J ). To test whether the gene expression changes were translated into protein levels, we measured the MRPL16, PMAIP1 and MDH1 and MAPK3 protein levels in AMD vs. normal RPE. Western blot analyses followed by densitometry did not show a significant difference in these protein levels in normal RPE as compared to AMD RPE ( Supplementary Fig. 1B-L ). This could be due to various levels of post-transcriptional and post-translational regulations and a high variability for correlation for various genes. Nonetheless, a small variation in gene expression could induce metabolic and epigenetic changes in a cell. Thus, our observations of differential expression of the above genes could have metabolic and biological effects in the RPE cells. overactive mtoR pathway in AMD Rpe. SIRT1 negatively regulates mTOR 48 , and we observed a decrease in SIRT1 levels and increased PGC-1α acetylation in AMD RPE. We, therefore, sought to test the mTOR pathway in AMD versus normal RPE. We measured the levels of mTOR phosphorylation at Ser2448, and the mTOR target protein 49 , the ribosomal protein S6 kinase (p70S6K) phosphorylation at Thr389, which indicates the mTORC1 activity. We also analyzed the levels of total mTOR protein in AMD as compared to normal RPE. Our data showed that phospho mTOR (Ser2448) was increased in AMD RPE as compared to normal RPE at 1 h after IGF-1 incubation (Fig. 3A,B ). The mTOR total protein levels were also significantly higher in AMD RPE as compared to normal RPE (30 minutes IGF-1 incubation, Fig. 3A,C) . The level of phospho p70 was induced by IGF-1 after 15 minutes incubation followed by a decrease after 30 minutes in normal RPE, in AMD RPE; however, the phsopho p70 was significantly higher in the absence of IGF-1 and was sustained until 1 h after incubation with IGF-1 (Fig. 3A,D) .
To further investigate the mTOR hyperactivity and AMPK inactivity in AMD RPE, we analyzed Raptor (792) phosphorylation, which inhibits the Raptor-containing mTOR complex 1 (mTORC1), and is a direct substrate of AMPK 50 . Western blot analyses showed that the basal phosphorylation levels of Raptor (792) during starvation Metabolic dysregulation in AMD Rpe. To investigate the metabolic dysregulation, we analyzed untargeted metabolomic and lipidomic profiling of AMD RPE and normal RPE cell extracts using high-resolution mass spectrometry. We acquired LC-MS data for 5 AMD samples and 4 normal samples. Each sample was run in triplicates, generating a total of 27 LC-MS spectra; however, technical replicates were not used for statistical analysis. The data were acquired in positive and negative ionization modes. The R-package XCMS was used to preprocess the datasets acquired in the electro-spray positive and negative ion modes and to detect the peaks.
2653 metabolite ions were detected in the positive mode, and 2542 ions were detected in the negative mode from the metabolomics profiling data.
Lipidomics profiling detected 1155 and 1699 peaks in the positive and negative ionization modes, respectively. Following data pre-processing, outlier screening was performed, and one AMD sample, and one normal sample were removed that behaved differently compared to other spectra as an outlier. A principal component analysis (PCA) analysis was performed on the preprocessed data. The score plots showing the similarities and differences between the metabolomics profiles of AMD and control are shown in Supplementary Fig. 3 .
T-test was performed to identify ions with significant changes in intensity levels between AMD and control. Table 1 shows the number of significant ions selected for each analysis. As shown in Table 1 , there were several ions that were significant with a p-value < 0.05, but very few were selected when adjusted for multiplicity using the Benjamini-Hochberg procedure for determining the false discovery rate at ≤5%.
Putative identifications for the resulting ion list were obtained using the software MetaboQuest [http:// omicscraft.com/MetaboQuest/], wich searched for putative identifications against multiple databases such as HMDB, METLIN, KEGG, MMCD, and LIPID MAPS. A mass tolerance of 10ppm was used to perform the database search. Pathway analysis was performed on a selected set of putative identifications that were filtered based on a literature search. Ions from positive and negative modes were combined for further analyses. 46 metabolites and 13 lipids with putative identifications were selected for further analyses after a literature search on the putative identifications. Figure 4A ,B show the heatmap of these selected metabolites (4A) and lipids (4B). MetaboAnalyst 51 was used to identify the pathways that are associated with the selected metabolites and lipids. From our analysis, a few metabolites such as glutathione, guanosine, and L-glutamic acid were found to be downregulated in AMD RPE as compared to normal RPE. The identity of these metabolites was confirmed by tandem mass spectrometry. MS/MS fragmentation patterns of the glutamic acid and glutathione against standards are shown in Supplementary Fig. 4 . Dysregulation of these metabolites has been reported to be associated with oxidative stress and neurotoxicity [52] [53] [54] , cellular metabolism and stress resistance 55 , and recovery of mitochondrial membrane potential 56 ; the findings by global MS profiling were strongly corroborated by our biochemical studies which showed a significant decrease in NADt in AMD RPE (Fig. 1C ).
Overrepresentation analysis with the hypergeometric test was used to determine if the dysregulated metabolites represent an enrichment of a particular pathway. Figure 5A ,B represents the pathways selected for metabolomics (5A) and lipidomics (5B) data, which showed overlapping pathway enrichment for both sets of analyses. Interestingly, these metabolic pathways have been associated with AMPK/PGC-1α pathway in various studies [57] [58] [59] [60] [61] [62] [63] and further support our observations on the implication of AMPK/SIRT1/PGC-1α and metabolic pathways in AMD.
Glycerophospholipid metabolism is significantly different in metabolomics and lipidomics data between AMD and normal RPE. The molecules involved in the glycerophospholipid metabolism pathway from the metabolomics and lipidomics analyses are Phosphatidylethanolamine (C00350), involved in the autophagy pathway, Phosphatidylcholine (C00157) involved in alpha-linolenic and linoleic acid metabolisms, 1-Acyl-sn-glycero-3-phosphocholine (C04230) and Phosphatidylserine (C02737) involved in lipid and protein metabolisms.
To recapitulate our observations on gene expression, proteins, metabolomics, and lipidomics, we combined our data using the ingenuity pathway analysis tool and generated a combined network shown in Fig. 6 , which showed a strong correlative network between metabolite indicators of oxidative stress with the expression of AMPK and Sirtuins.
In addition, we used the Pathway Studio to generate a recapitulative pathway analysis of all metabolic pathways that are related to our observations and could be involved in AMD (Fig. 7) . 
Discussion
In this study, we identified dysregulated metabolic pathways in AMD RPE as compared to normal RPE. We observed increased PARP2 expression resulting in reduced NAD+ and SIRT1 and increased acetylated PGC-1α in AMD RPE. We also show reduced AMPK activity and hyperactive mTOR signaling in AMD RPE. These pathways are interrelated, and dysregulation of one will affect the other. Metabolomic analyses further revealed dysregulated metabolites and lipids contributing to oxidative stress and energy metabolism in AMD RPE as www.nature.com/scientificreports www.nature.com/scientificreports/ compared to normal RPE. Collectively, our study proposes dysregulation of AMPK/SIRT1/PGC-1α and overactive mTOR as underlying disease mechanisms in AMD RPE.
PARP2 is upstream of SIRT1 and inhibits SIRT1 translation, therefore regulating oxidative metabolism 34 . SIRT1 activity is NAD+ dependent, and a reduction in NAD+ can affect SIRT1 activity. We observed an increase in PARP2 expression and decreased NADt in the AMD RPE compared to normal RPE. Increased PARP2, a consuming NAD+ enzyme, can inhibit SIRT1 levels, therefore lowering mitochondrial biogenesis through acetylation and deactivation of PGC-1α, which will result in decreased mitochondrial oxygen consumption 34 .
Concordant with our data, a new study showed that nicotinamide ameliorates disease phenotypes in an induced pluripotent stem cell model of AMD 64 . In addition, we observed decreased AMPK activity, as shown by decreased pAMPK and pACC levels in AMD RPE as compared to normal RPE. AMPK is a direct regulator of PGC-1α, and reduced AMPK activity could affect PGC-1α activity and expression. Recent studies report on the role of PGC-1α in regulating retinal angiogenesis in normal and pathological conditions 23, 40 , as well as oxidative metabolism and antioxidant capacity in RPE 41 , and light sensitivity in the retina 23 . Nonetheless, the role of PGC-1α in AMD pathophysiology has yet to be discovered. Here we show that the PGC-1α acetylated form was increased in the AMD RPE as compared to normal RPE due to lower SIRT1 levels. Reduced PGC-1α activity could affect autophagy and mitochondrial biogenesis and consequently induce disease phenotypes that we observed in AMD RPE 10 .
Impaired mTOR activity has been involved in age-related diseases 39, 65 , and neurological disorders, including neurodegenerative diseases 39 . www.nature.com/scientificreports www.nature.com/scientificreports/ mTOR is shown to inhibit autophagy by phosphorylating ULK-1 and disrupting the interaction between ULK-1 and AMPK 37 . Another study reported that mTOR regulates autophagy termination and lysosomal reformation 66 . We have observed that phospho mTOR and total mTOR were increased in AMD as compared to normal RPE. We have also observed that mTOR target protein, p70S6K, is rapidly and sustainably activated by . Crosstalk of metabolic pathways in AMD. Upregulation of PARP2 expression in AMD leads to negative regulation of SIRT1. Depletion of SIRT1 protein, a NAD+ -dependent deacetylase, results in acetylation and inactivation of PGC-1α. SIRT1 downregulation leads to TORC1 complex activation in AMD that negatively regulates autophagy by phosphorylation-dependent inhibition of Atg13 and ULK1. Activated mTOR is also a positive regulator of glycolysis. MAPK3 was downregulated in AMD RPE; which can result in higher expression of PMAIP1 mRNA coding NOXA protein. This protein promotes mitochondrial membrane changes and efflux of apoptogenic proteins from the mitochondria. MDH1, an important gene that plays a role in energy metabolism was upregulated in AMD RPE cells. This cytosolic isozyme plays a key role in the malate-aspartate shuttle that allows malate to pass through the mitochondrial membrane. It also performs NAD/NADH-dependent reversible oxidation of oxaloacetate to malate. The activity of the energy sensor protein kinase, AMPK, was reduced in AMD RPE cells, which may lead to dysregulation of catabolic and anabolic processes, and to further downregulation of PGC1α and SIRT1. Proteins are shown according to their localization in the cell (nucleus, mitochondria, cytoplasm). Blue arrows indicate regulation of expression; green arrows indicate protein modification or binding; dash arrows show indirect regulation, and black arrows represent direct regulation. The green color of protein or cellular process indicates downregulation in AMD vs. normal RPE cells. The red color of protein or cellular process indicates upregulation in AMD vs. normal RPE. The pathway analysis was performed using Pathway Studio.
IGF-1 in AMD RPE compared to normal RPE, suggesting mTOR hyperactivity in AMD RPE. Furthermore, we found that Raptor (Ser792) phosphorylation, a direct target of AMPK, is inhibited in AMD, indicating repressed AMPK pathway in AMD RPE.
Relevant to the current study, altered mTOR signaling was reported in senescent RPE in vitro 67, 68 . mTOR has also been shown to mediate the dedifferentiation of the RPE and initiate photoreceptor degeneration 69 .
mTOR is known to play a pivotal role in regulating lipid synthesis and storage, and inhibition of β-oxidation 70 . Furthermore, mTOR activation is associated with glycolysis and increased glycogen storage 71 . In our recent study, we analyzed AMD RPE by electron microscopy and observed increased lipid droplets and glycogen granules. We also observed that ATP was mainly generated by glycolysis in AMD RPE 10 . These observations are in line with our current observation of mTOR overactivity in AMD RPE.
It is reported that mTOR is required for the preservation of mitochondrial oxidative function through YY1-PGC-1alpha transcriptional complex 72 . While mTOR is crucial for mitochondrial biogenesis and activity 73 , an overactive mTOR inhibits AMPK and negatively impacts autophagy/mitophagy 36 . A recent study reported that AMD RPE are more resistant to oxidative stress after incubating the RPE under stress conditions for 24 hrs 74 . In our previous work, longer exposure to oxidative stress up to 48hrs showed that AMD RPE were more sensitive to oxidative stress-induced cell death as compared to normal RPE 10 . The same study showed that PGC-1α is increased in the RPE of AMD donors. This discrepancy could be explained by different AMD stages as RPE from donors with early AMD might first express higher PGC-1α levels as a compensatory response to excessive oxidative stress and due to higher mTOR activity 75 , however, what is biologically relevant is PGC-1α activity. Our data show that acetylated PGC-1α (inactive form) is higher in AMD vs. normal RPE. Therefore, even in the presence of higher PGC-1α gene expression as a result of mTOR hyperactivity during early AMD stages, a reduction in PGC-1α activity in later stages could ultimately affect mitochondrial turnover and biogenesis causing increased ROS production and cell death.
AMPK is known to increase PGC-1α expression, and directly phosphorylates and activates PGC-1α 76 . AMPK also induces PGC-1α activation through SIRT1-mediated PGC-1α deacetylation 25 . Thus, a tight regulation between mTOR and AMPK pathways is necessary for PGC-1α regulation and function. An imbalance in the activity of these pathways can directly affect PGC-1α activity and consequently mitochondrial biogenesis and oxidative metabolisms, inducing AMD disease cellular phenotypes.
Retinal diseases, including AMD, are related to mitochondrial dysfunction 10, 77, 78 . Impaired mitochondria induce metabolic dysfunction, increased levels of ROS, and cell death 79 . Our data show that MRPL16, a protein-coding gene that plays a role in mitochondrial translation and PMAIP1, a protein that promotes activation of caspases and is implicated in mitochondrial damage and apoptosis, are upregulated in AMD RPE. In addition, our data revealed increased expression of MDH1, an enzyme catalyzing the transport of NADH throughout the mitochondrial membrane, and promoting reversible oxidation of oxaloacetate to malate 45 . These findings were consistent with the increase in metabolite indicators of oxidative stress. We also observed decreased expression of MAPK3, a gene that is involved in multiple cellular processes in a variety of extracellular signals. Interestingly, It is reported that MDH1 can positively regulate PMAIP1 80 , whereas MAPK3 inhibits PMAIP1 81 . These findings further support that AMD is a metabolic disease caused by mitochondrial damage and impairment in metabolic activities.
Downregulated AMPK/SIRT1/PGC-1α pathway and overactive mTOR led us to investigate metabolomics/ lipidomics in the AMD RPE and normal RPE. Our data showed that the endogenous levels of specific lipids and metabolites are altered in AMD RPE as compared to normal RPE. Modifications in lipid metabolism could have multiple consequences including changes in gene expression and cellular functions, protein distribution and function and membrane compositions, which could lead to development of inflammation and various diseases 82 . Our metabolomic and lipidomic pathway analyses revealed certain pathways that were differentially expressed in normal vs AMD RPE. Interestingly, these pathways are associated with AMPK/SIRT1/PGC-1α pathway [57] [58] [59] [60] [61] [62] [63] , further supporting our observations. The glycerophospholipid metabolism pathway significantly differed in AMD and normal RPE (Fig. 5A,B) . Interestingly, the phosphatidylethanolamine (PE) is one of two dominant glycerophospholipid classes in the vertebrate retina and the rod outer segment membranes and is involved in membrane transport of visual pigments 83 .
We combined significant metabolites and lipids with the genes that were selected from our RNA-Seq data and biochemical analyses to create a combined network using Ingenuity Pathway Analysis (IPA) tool (Fig. 6) . The molecules in the network are mainly involved in cell functions, cell death and survival, neurological diseases, and organismal injury. The network analysis revealed that NADP selected from biochemical analysis and L-glutamic acid selected from the LC-MS analysis belong to the same Glutamate Biosynthesis II pathway. Glutathione 84 , guanosine 85 , L-glutamic acid 86 , and PPARGC1A (PGC-1α) are also involved in the depolarization of the mitochondrial membrane 56, [87] [88] [89] and the density of mitochondrial cristae 90 . The metabolites, reduced form of glutathione, and L-glutamic acid are found to be downregulated in our metabolomics and lipidomics analysis in AMD as compared to normal RPE.
Using Pathway Studio, we have recapitulated our biochemical and molecular analyses in Fig. 7 .
In summary, our data provide strong evidence for the involvement of AMPK/SIRT1/PGC-1α and mTOR pathways in AMD RPE and propose dysregulation of metabolic pathways as underlying mechanisms in AMD.
Our study provides new insights for the development of novel treatment strategies in AMD pathophysiology. While these in vitro analyses provide critical information for a better understanding of the underlying mechanisms of AMD, further in vivo analyses are required to confirm the in vitro observations. Scientific RepoRtS | (2020) 10:2464 | https://doi.org/10.1038/s41598-020-59244-4
www.nature.com/scientificreports www.nature.com/scientificreports/ Methods isolation and culture of Rpe from deceased donor eyes. De-identified clinically diagnosed AMD (2 male and 3 female) and normal eyes (4 male and 3 female) were purchased from National Disease Research Interchange (NDRI, Philadelphia, PA, USA) 91 , a gift from Dr. Hathout, under an exempt IRB (NDRI). The eyes of donors with other ocular diseases or diabetes were excluded from the study. The average postmortem enucleation time was 9 h, and eyes were received in <24 h. NDRI performed serology tests and samples with infectious diseases were excluded (Table 1) . RPE were isolated from the macula region according to established protocols 92 , and cultured in serum-free media 93 with controlled oxygen (5%) and CO2 (5%) 94 . We then purified RPE by magnetic-activated cell sorting through positive selection with anti-BEST1 antibody (Abcam, Cambridge, MA, USA, 1/500) and anti-E-cadherin (Miltenyi Biotech, San Diego, CA, USA, 1/200); followed by a negative selection with anti-fibroblast MicroBeads (Miltenyi Biotech, 1/200) to eliminate fibroblasts 10, 78 . To reduce heterogeneity, the highly epitheloid RPE colonies were manually selected and cultured.
All methods were carried out in concordance with relevant guidelines and regulations. All experimental protocols were approved by a named institutional and/or licensing committee.
transcriptome sequencing and analysis. Whole RNA was extracted from RPE cells, and 5 ug was processed to generate sequencing libraries using the Ilumina TruSeq protocol. The library was subjected to paired-end sequencing (50 nt read length, 25 mln reads) on Illumina HiSeq2000 platform. Raw sequencer reads were processed using Illumina's RTA and CASAVA pipeline software that includes image analysis, sequence quality scoring, and base calling. TopHat2 was used to align the quality-filtered sequencing reads. Sequences were aligned to the human genome reference genome, and transcripts were assembled using Cufflinks 95 . The abundance was evaluated as fragments per kilobase of exon per million fragments mapped (FPKM). Differential expression analysis is performed using the Cuffdiff utility of Cufflinks. Table 4 ), and bands were revealed using the Clarity Chemiluminescent Substrate (Biorad) and captured with X-ray films. ImageJ software was used to perform densitometry analyses. For IGF-1 dependent phosphorylation analyses, the monolayer of AMD and normal RPE were cultured in serum free media and starved in HBSS for 2hrs followed by incubation with IGF-1 (75 ng/ml) for the indicated times.
Quantitative reverse transcription and polymerase chain reaction (qRt-pcR
image processing. Western blots are presented in raw format without any image processing. X-rays were scanned, and the Tiff files were color-inverted to gray scale. All raw images are presented in Supplementary Fig. 2 , which includes all uncropped gels that were used to prepare Figs. 1-3 , and Supplementary Fig. 1. immunoprecipitation. Protein samples were extracted by Immunoprecipitation (IP) Buffer containing 25 mM Tris-HCl PH 7.4, 1% NP-40, 1 mM EDTA, 150 mM NaCl, and 5% Glycerol and freshly added Protease and Phosphatase Inhibitors (Invitrogen). Protein concentrations were determined using Pierce ™ BCA Protein Assay Kit (Thermofisher). 150 μg Protein samples were incubated with anti-Acetyl Lysine Antibody conjugated-agarose beads (Immunechem) and incubated overnight at 4 °C. Agarose beads were then washed three times in IP buffer followed by three times wash in TAE buffer and incubated for 5 minutes at 95 °C in NuPAGE LDS Sample Buffer (Invitrogen). Supernatants were collected after brief centrifuge and were cooled at room temperature before loading. Western blots were revealed with anti-PGC-1α antibody (Millipore) to determine PGC-1α acetylated protein levels.
Metabolomics and lipidomics. Metabolite extraction was performed using modification of the protocol described by Sheikh et al. 96 . Briefly, cells were harvested by removing the media and washing with PBS, followed by cell scraping. Metabolite extraction was performed using sequential extraction as described by Sheikh www.nature.com/scientificreports www.nature.com/scientificreports/ Statistical analysis. Experiments were repeated at least 3 times. For gene expression analyses, 3 replicas of each sample were represented per experiment, and mean averages ± SEM were calculated. We performed one-way ANOVA followed by Dunnett's multiple comparisons test using GraphPad Prism version 7.00 for Mac, GraphPad Software, La Jolla, California, USA. The statistical significance was determined as a p-value < 0.05.
For Metabolomics and lipidomics data analyses, centroided and integrated mass spectrometry data from the UPLC-TOFMS were processed using XCMS (Scripps Institute) to generate a data matrix containing ion intensities, mass to charge (m/z) and retention time values. Pathway analyses were performed using MetaboAnalyst 4.0 (PMID: 29762782), and the networks were generated using Ingenuity Pathway Analysis tools (QIAGEN Inc., https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis).
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
